[1/3] 🧵 The Clinical Research Committee endorses academically led, industry-sponsored clinical trials, allowing them to access research support. Follow along to hear about our most recent recipients 👇 Explore our Clinical Research Committee: bit.ly/3FiietN

[2/3] Christopher Fox received an endorsement for the phase 2 RADICAL trial using four novel prognostic tools to identify patients with high-risk large B-cell #lymphoma & evaluating outcomes of adding epcoritamab to standard chemo-immunotherapy. Chris Fox | University Hospital Southampton 💙

[3/3] Andrew Clamp received an endorsement for the phase 3 SALVOVAR trial to assess if weekly dose-dense chemotherapy improves survival in a specific subpopulation of advanced #ovariancancer patients with poorly chemosensitive disease. UCL

[1/5] Getting the right data at the right time is essential for researchers looking to beat cancer sooner. Using advanced data modelling and AI, the CD3 programme is a £10m commitment to better understanding cancer.🔬 However to deliver on its promise Government must:

Are you a cancer prevention researcher uncovering new insights in the field? Share your work with a global audience at #PrevConf25. 🚨 Submit your abstract by 21 March. Submit abstract: bit.ly/4h8H64z American Cancer Society | National Cancer Institute

#ICYMI: Researchers Richard Mair & Juanita Lopez are bringing new hope to people affected by #Glioblastoma. The 5G trial is a first-of-its-kind precision adaptive platform trial testing existing therapies proven safe and effective in other cancers. 🌟 Read more about 5G:

🌟 Our #ResearchIsBeautiful campaign continues to inspire! Congratulations to Danny Gold from the University of Oxford for his stunning image which captures microtubules attaching to chromosomes via kinetochores to form mitotic spindles. Hear more from

This series spotlights various topics related to equity, diversity and inclusivity in cancer research. The next seminar focuses on our communities, and how researchers can work effectively with public contributors to achieve excellent research outcomes Join the webinar 👇

🚨 Abstract submissions for #PrevConf25 close today! Don't miss this chance to present your prevention research to a global audience at the Cancer Prevention Research Conference this summer. Submit abstract: bit.ly/4h8H64z American Cancer Society | National Cancer Institute

We spoke with Sally George from The ICR about the Stratified Medicine Paediatrics 2 study & their recent publication in Cancer Discovery. The team’s research showed how ctDNA sequencing provides crucial insights into tumour evolution in young cancer patients. 🔗 Read more from

We had too many to choose from in last month’s round of #ResearchIsBeautiful entries, so here’s a roundup of the ones that came out best of the rest!🔗bit.ly/41T021H Don’t forget - there’s just one day left to submit for the March round. We want to see anything that

[1/4] 🧵 Introducing the latest researchers granted our Biology to Prevention Award by our Prevention and Population Research Committee 👇 Learn more about their research & find out about the scheme here: cruk.org/PRCbiology

[2/4] Karin Hellner gained a Biology to Prevention Award to develop and test the immunogenicity of an mRNA vaccine against all oncogenic human papillomaviruses to treat persisting infections in patients undergoing resection for #cervicalcancer. #CRUKFunded University of Oxford

[3/4] Rebecca Fitzgerald & John Lizhe Zhuang will uncover mechanisms of proliferation in hereditary diffuse #gastriccancer to identify therapeutic targets & reduce life-altering gastrectomies. #CRUKFunded Rebecca Fitzgerald Lab | Rebecca Fitzgerald | John Lizhe Zhuang | Cambridge University

[4/4] Andrew Gilmore, Sacha Howell, Susan Astley Theodossiadis & Sankari Nagarajan will identify mammographic and genetic markers of response to preventive tamoxifen in #breastcancer to inform novel prevention strategies for resistant patients. #CRUKFunded The University of Manchester

[1/3] Excited to announce the incredible researchers selected by our Prevention and Population Research Committee for Programme Awards 🎉 Read on to learn about their projects and find out more about the scheme: cruk.org/PRCprogramme

[2/3] Ruth Langley & John Burn will investigate platelet activation suppression by aspirin & its effect on tumour immunogenicity to expand understanding of anticancer mechanisms and validate urinary 11-dehydro-TXB2 as a biomarker for aspirin responders. #CRUKFunded Ruth Langley

[3/3] Bernard Rachet & Ellen Nolte will evaluate how multiple sociodemographic factors interact leading to inequalities in cancer care & outcomes across England and propose strategies to reduce the impact of these inequalities. #CRUKFunded London School of Hygiene & Tropical Medicine

Yoryos Lyratzopoulos & Matthew Barclay received a Project Award to assess whether optimal #lungcancer treatment is consistent across geographical locations and if treatment variation impacts survival. Find out more: cruk.org/PRCproject #CRUKFunded Matthew Barclay | UCL